FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. - FDA approves Zepbound for sleep apnea in obese adults - FDA approves first medication for obstructive sleep apnea, which also promotes weight loss - Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea - FDA approves weight loss drug Zepbound to treat obstructive sleep apnea - Weight loss drug gets US nod to treat sleep apnea; India launch likely next year - FDA approves weight loss drug Zepbound for sleep apnea - The FDA just approved Eli Lilly's Zepbound for sleep apnea -- and Medicare coverage could be next - FDA approves weight-loss drug to treat sleep apnea